207 related articles for article (PubMed ID: 37753370)
1. Suberoylanilide hydroxamic acid upregulates reticulophagy receptor expression and promotes cell death in hepatocellular carcinoma cells.
Li JY; Tian T; Han B; Yang T; Guo YX; Wu JY; Chen YS; Yang Q; Xie RJ
World J Gastroenterol; 2023 Sep; 29(34):5038-5053. PubMed ID: 37753370
[TBL] [Abstract][Full Text] [Related]
2. Family with sequence similarity 134 member B-mediated reticulophagy ameliorates hepatocyte apoptosis induced by dithiothreitol.
Guo YX; Han B; Yang T; Chen YS; Yang Y; Li JY; Yang Q; Xie RJ
World J Gastroenterol; 2022 Jun; 28(23):2569-2581. PubMed ID: 35949353
[TBL] [Abstract][Full Text] [Related]
3. Suberoylanilide hydroxamic acid upregulates histone acetylation and activates endoplasmic reticulum stress to induce apoptosis in HepG2 liver cancer cells.
Yu L; Xie R; Tian T; Zheng L; Tang L; Cai S; Ma Z; Yang T; Han B; Yang Q
Oncol Lett; 2019 Oct; 18(4):3537-3544. PubMed ID: 31516571
[TBL] [Abstract][Full Text] [Related]
4. Effect of Decitabine (5-aza-2'-deoxycytidine, 5-aza-CdR) in Comparison with Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) on DNMT1, DNMT3a and DNMT3b, HDAC 1-3, SOCS 1, SOCS 3, JAK2, and STAT3 Gene Expression in Hepatocellular Carcinoma HLE and LCL-PI 11 Cell Lines.
Sanaei M; Kavoosi F; Pourahmadi M
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2089-2098. PubMed ID: 34319031
[TBL] [Abstract][Full Text] [Related]
5. Suberoylanilide hydroxamic Acid, a histone deacetylase inhibitor, alters multiple signaling pathways in hepatocellular carcinoma cell lines.
Kunnimalaiyaan S; Sokolowski K; Gamblin TC; Kunnimalaiyaan M
Am J Surg; 2017 Apr; 213(4):645-651. PubMed ID: 28007318
[TBL] [Abstract][Full Text] [Related]
6. Suberoylanilide hydroxamic acid enhances chemosensitivity to 5-fluorouracil in hepatocellular carcinoma via inhibition of thymidylate synthase.
Liao B; Liang H; Chen J; Liu Q; Zhang B; Chen X
Tumour Biol; 2015 Dec; 36(12):9347-56. PubMed ID: 26108995
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma.
Yang H; Lan P; Hou Z; Guan Y; Zhang J; Xu W; Tian Z; Zhang C
Br J Cancer; 2015 Jan; 112(1):112-21. PubMed ID: 25393367
[TBL] [Abstract][Full Text] [Related]
8. The anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on the aggressive phenotypes of ovarian carcinoma cells.
Chen S; Zhao Y; Gou WF; Zhao S; Takano Y; Zheng HC
PLoS One; 2013; 8(11):e79781. PubMed ID: 24236158
[TBL] [Abstract][Full Text] [Related]
9. Novel SAHA analogues inhibit HDACs, induce apoptosis and modulate the expression of microRNAs in hepatocellular carcinoma.
Srinivas C; Swathi V; Priyanka C; Anjana Devi T; Subba Reddy BV; Janaki Ramaiah M; Bhadra U; Bhadra MP
Apoptosis; 2016 Nov; 21(11):1249-1264. PubMed ID: 27502208
[TBL] [Abstract][Full Text] [Related]
10. ING5-mediated antineuroblastoma effects of suberoylanilide hydroxamic acid.
Wu JC; Jiang HM; Yang XH; Zheng HC
Cancer Med; 2018 Sep; 7(9):4554-4569. PubMed ID: 30091530
[TBL] [Abstract][Full Text] [Related]
11. [Dithiothreitol promotes apoptosis in rat hepatocytes by inhibiting family with sequence similarity 134 member B (FAM134B)-mediated endoplasmic reticulophagy].
Guo Y; Han B; Yang T; Chen Y; Yang Y; Liang C; Li J; Yang Q; Xie R
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Dec; 38(12):1104-1110. PubMed ID: 36585233
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis through both mitochondrial and Fas (Cd95) signaling in head and neck squamous carcinoma cells.
Gillenwater AM; Zhong M; Lotan R
Mol Cancer Ther; 2007 Nov; 6(11):2967-75. PubMed ID: 18025281
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling.
Hsu FT; Liu YC; Chiang IT; Liu RS; Wang HE; Lin WJ; Hwang JJ
Int J Oncol; 2014 Jul; 45(1):177-88. PubMed ID: 24807012
[TBL] [Abstract][Full Text] [Related]
14. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.
Chen MC; Huang HH; Lai CY; Lin YJ; Liou JP; Lai MJ; Li YH; Teng CM; Yang CR
Oncotarget; 2016 Jan; 7(1):402-17. PubMed ID: 26587975
[TBL] [Abstract][Full Text] [Related]
15. Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo.
Tzao C; Jin JS; Chen BH; Chung HY; Chang CC; Hsu TY; Sun GH
Dis Esophagus; 2014; 27(7):693-702. PubMed ID: 24033428
[TBL] [Abstract][Full Text] [Related]
16.
Bi T; Lu Q; Pan X; Dong F; Hu Y; Xu Z; Xiu P; Liu Z; Li J
Cell Cycle; 2023 Sep; 22(17):1900-1920. PubMed ID: 37603831
[TBL] [Abstract][Full Text] [Related]
17. Excessive ER-phagy mediated by the autophagy receptor FAM134B results in ER stress, the unfolded protein response, and cell death in HeLa cells.
Liao Y; Duan B; Zhang Y; Zhang X; Xia B
J Biol Chem; 2019 Dec; 294(52):20009-20023. PubMed ID: 31748416
[TBL] [Abstract][Full Text] [Related]
18. Histone Deacetylase (HDAC) Inhibitor, Suberoylanilide Hydroxamic Acid (SAHA), Induces Apoptosis in Prostate Cancer Cell Lines via the Akt/FOXO3a Signaling Pathway.
Shi XY; Ding W; Li TQ; Zhang YX; Zhao SC
Med Sci Monit; 2017 Dec; 23():5793-5802. PubMed ID: 29211704
[TBL] [Abstract][Full Text] [Related]
19. Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells.
You BR; Han BR; Park WH
Oncotarget; 2017 Mar; 8(11):17726-17737. PubMed ID: 28099148
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of SAHA, a novel histone deacetylase inhibitor, against murine B cell lymphoma A20 cells in vitro and in vivo.
Yang B; Yu D; Liu J; Yang K; Wu G; Liu H
Tumour Biol; 2015 Jul; 36(7):5051-61. PubMed ID: 25649979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
